NCT00716716 - Phase I/IIa Study of FIXFc in Hemophilia B Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Hemophilia B

Interventions

DRUG

rFIXFc

As specified in the treatment arm

Trial Locations (6)

Hemophilia Center of Western PA, Pittsburgh

University of North Carolina Medical School, Chapel Hill

Indiana Hemophilia & Thrombosis Center, Indianapolis

RUSH University Medical Center, Chicago

Puget Sound Blood Center, Seattle

Brigham & Women's Hospital, Boston